Other News To Note
Friday, June 15, 2012
International Stem Cell Corp., of Carlsbad, Calif., said that scientists in its wholly owned subsidiary, Lifeline Cell Technology, modified human stem cells using transducible transcription factors (TTF), a type of protein engineered to pass into stem cells and direct changes into specific cell types. The method does not require viruses or chemicals, and TTF proteins are naturally eliminated when no longer required.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.